Discusses 2026 Clinical Pipeline Outlook and Anticipated Trial Updates February 2, 2026 7:01 PM ESTCompany ParticipantsGary ...

To kick off mock draft season, I decided to use mock drafts as a way to start our look at potential draft targets for the Dolphins this year. I visited our friends at Pro Football and Sports Network ...

The FDA accepted an application for ivonescimab with chemotherapy for patients with lung cancer driven by EGFR changes after prior targeted treatment.

BPC-157 hasn't been approved by the FDA. But that hasn't stopped this buzzy drug from gaining traction – and attention from MAHA.

The gray market is awash with BPC-157, a drug hyped as a cure-all, but unapproved by the FDA. Will RFK Jr. change that?

Medications targeting the neonatal fragment crystallizable receptor have gained attention due to multiple recent FDA ...

Detailed price information for Corvus Pharma Com (CRVS-Q) from The Globe and Mail including charting and trades.

Albert Bourla: 2025 was a very good year for Pfizer Inc. I'm very pleased with strong execution to deliver and, frankly, overdeliver on our financial commitments. If successful, we will substantially ...

Even after a blood clot is removed from a large artery in the brain via a minimally invasive procedure to treat a clot-caused ...

Ginger and peppermint can help ease nausea, but ginger is often more effective due to compounds such as gingerols and shogaols.

Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) (“Acurx” or the “Company”), a late-stage biopharmaceutical company developing a new class of antibiotics for difficult-to-treat bacterial infections, ...

Objective To determine whether liquefied petroleum gas (LPG) can reduce perinatal mortality in a setting with high reliance ...